Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata

Fertility and Sterility

Volumn 75, Issue 3, 2001, Pages 632-633

  De Leo, Vincenzo ^a   Marca, Antonio ^a   Morgante, Giuseppe ^a   Severi, Filiberto Maria ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN DERIVATIVE;

FEMALE; HUMAN; LEIOMYOMA; LETTER; PRIORITY JOURNAL; SHORT SURVEY; UTERUS MYOMA;

EID: 0035109727     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)01738-6     Document Type: Article

References (16)

1. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
2. Regression of uterine leiomyomata in response to the antiprogestine RU 486
3. Effect of growth hormone and its combination with estradiol-17β on the uterus of hypophysectomized-ovariectomized rats
4. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium
5. Uterine leiomyomata-a feature of acromegaly
6. The secretion of insulin-like growth factor-I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist
7. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata
8. Insulin-like growth factor I and II binding in human myometrium and leiomyomas
9. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyoma
10. Expression of insulin-like growth factor I and II genes in human smooth muscle tumours
11. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues
12. Insulin-like growth factor gene expression in human smooth muscle tumors
13. Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014
14. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist
15. Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the rat
16. A role for the insulin-like growth factors as estromedins in the rat uterus